Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
URGN · against 431 other Healthcare companies of similar size
Ranked #362 of 432 · scores higher than 14% of peers
Bars: peers in each 10-point band of the profitability score39 peers with a profitability score of 10–19, including URGN · Click a bar to see the companies
Mainly because of its return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | URGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 407 reported | Not reported | 5.6% | — | — | 33% |
| Operating marginHigher is better · 402 reported | -35.3% | 7.2% | 15% | 33% | |
| Return on assetsHigher is better · 416 reported | -38.7% | 2.0% | 8% | 33% | |
| Return on equityHigher is better · 400 reported | Not reported | 4.4% | — | — | Context only |
| Gross marginHigher is better · 446 reported | 90.8% | 47.1% | 95% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 362 | 927M USD | 18 | 41 | |
| 362 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 1.6B USD |
| 18 |
| 38 |
| 362 | 1.6B USD | 18 | 7 |
| 362 | 994M USD | 18 | 39 |
| 362 | 1.7B USD | 18 | 31 |
| 362 | 1.9B USD | 18 | 42 |
| 371 | 1.0B EUR (≈$1.1B) | 17 | 16 |
| 371 | 1.9B USD | 17 | 32 |
| 373 | 1.5B USD | 16 | 26 |